Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria P Sormani

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patientsPaolo Bruzzi, Lucia Del Mastro, Maria P Sormani, et al.
Journal of the Peripheral Nervous System : JPNS|November 14, 2018
Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up studyLuana Benedetti, Chiara Briani, Alessandro Beronio, et al.
Journal of the Peripheral Nervous System : JPNS|June 15, 2007
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin MLuana Benedetti, Chiara Briani, Marina Grandis, et al.
Journal of Neurology|February 16, 2008
A three-year, multi-parametric MRI study in patients at presentation with CISMaria A Rocca, Federica Agosta, Maria P Sormani, et al.
Journal of the Peripheral Nervous System : JPNS|October 13, 2015
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathyMaria A Alberti, Laura Mori, Luca Francini, et al.
International Journal of Cancer|June 6, 2008
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progressionRita Rotondo, Luca Mastracci, Tiziana Piazza, et al.
Annals of Neurology|January 22, 2021
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple SclerosisMaria P Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populationsEline Me Coerver, Sezgi Kaçar, Olga Ciccarelli, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patientsPaolo Bruzzi, Lucia Del Mastro, Maria P Sormani, et al.
Journal of the Peripheral Nervous System : JPNS|November 14, 2018
Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up studyLuana Benedetti, Chiara Briani, Alessandro Beronio, et al.
Journal of the Peripheral Nervous System : JPNS|June 15, 2007
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin MLuana Benedetti, Chiara Briani, Marina Grandis, et al.
Journal of Neurology|February 16, 2008
A three-year, multi-parametric MRI study in patients at presentation with CISMaria A Rocca, Federica Agosta, Maria P Sormani, et al.
Journal of the Peripheral Nervous System : JPNS|October 13, 2015
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathyMaria A Alberti, Laura Mori, Luca Francini, et al.
International Journal of Cancer|June 6, 2008
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progressionRita Rotondo, Luca Mastracci, Tiziana Piazza, et al.
Annals of Neurology|January 22, 2021
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple SclerosisMaria P Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Nature Reviews. Neurology|July 8, 2015
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic processÀlex Rovira, Mike P Wattjes, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populationsEline Me Coerver, Sezgi Kaçar, Olga Ciccarelli, et al.
Pageof 3